Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Aug 10, 2015 at 1:55 PM EDT

Cancer Genetics to Acquire Assets of Response Genetics

Response Genetics has executed an asset purchase agreement with Cancer Genetics as a "stalking horse" bidder to potentially acquire all…

Jon C. Ogg | Aug 10, 2015 at 1:45 PM EDT

2 Analysts Continue to Like Shire-Baxalta Deal Pursuit

Baxalta has not been public as a standalone entity very long at all, when you consider that Shire is now…

Chris Lange | Aug 10, 2015 at 10:50 AM EDT

Massive Additional Gains in Aquinox Driven by Large Shareholder Stake

It is day two of the massive rally of Aquinox Pharmaceuticals, and the stock is continuing to push higher.

Chris Lange | Aug 10, 2015 at 9:10 AM EDT

MannKind Cheered Despite Lower Afrezza Shipments

MannKind reported a smaller than expected second-quarter net loss before the markets opened on Monday.

Lee Jackson | Aug 10, 2015 at 8:20 AM EDT

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

Merrill Lynch has looked at large cap biotech leaders and how interest rate increases may play a part in stock…

Jon C. Ogg | Aug 7, 2015 at 4:05 PM EDT

Janney Sees IBM and Merge Healthcare as Inconsequential

ThinkstockInternational Business Machines Corp. (NYSE: IBM) announced a small acquisition of Merge Healthcare (NASDAQ: MRGE) this week. The firm Janney…

Chris Lange | Aug 7, 2015 at 2:34 PM EDT

Key Analyst Sees Mylan as a Value Play

ThinkstockMylan N.V. (NASDAQ: MYL) is considered a serious value play in the health care sector by a key analyst. Argus…

Chris Lange | Aug 7, 2015 at 11:10 AM EDT

DepoMed Fires Back at Horizon Pharma

Shots were fired again on the Horizon Pharma and DepoMed merger front. However it was DepoMed this time pushing back.

Chris Lange | Aug 7, 2015 at 11:01 AM EDT

Can Aquinox Sustain Its Massive Rally?

Aquinox Pharmaceuticals made waves in the market Friday morning, with shares up over 200%, after it announced results from a…

Chris Lange | Aug 6, 2015 at 2:20 PM EDT

5 Big FDA Decisions Expected in August

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of August and…

Lee Jackson | Aug 6, 2015 at 8:35 AM EDT

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term…

Chris Lange | Aug 5, 2015 at 2:05 PM EDT

What to Expect From Allergan Earnings

Allergan is scheduled to report its second-quarter financial results Thursday before the markets open.

Jon C. Ogg | Aug 4, 2015 at 3:44 PM EDT

Will Biogen Win From Novartis MS Drug Safety Label Change?

ThinkstockThere are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc.…

Chris Lange | Aug 4, 2015 at 10:45 AM EDT

Starboard Value Sets Its Eyes on MedAssets

In an open letter to the chairman and CEO of MedAssets, Starboard Value outlines a plan to create more value,…

Lee Jackson | Aug 4, 2015 at 9:35 AM EDT

UBS Makes August Changes to Equity Focus List Portfolio

In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.

1 … 251 252 253 254 255 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Cancer Genetics to Acquire Assets of Response Genetics

2 Analysts Continue to Like Shire-Baxalta Deal Pursuit

Massive Additional Gains in Aquinox Driven by Large Shareholder Stake

MannKind Cheered Despite Lower Afrezza Shipments

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

Janney Sees IBM and Merge Healthcare as Inconsequential

Key Analyst Sees Mylan as a Value Play

DepoMed Fires Back at Horizon Pharma

Can Aquinox Sustain Its Massive Rally?

5 Big FDA Decisions Expected in August

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

What to Expect From Allergan Earnings

Will Biogen Win From Novartis MS Drug Safety Label Change?

Starboard Value Sets Its Eyes on MedAssets

UBS Makes August Changes to Equity Focus List Portfolio

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

Why SpaceX Is About to Spend Billions on Something It Can’t Launch

Emerging Markets Are Embarrassing the S&P 500: EEM Up 28% YTD

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

The 401(k) Bracket Smoothing Math: Why a 66 Year Old Couple With $1.5 Million Should Convert Exactly $90,000 a Year

Forget VOO: Fidelity’s Tech ETF Is Up 29% While the Broad Market Lags

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

Health and Healthcare Articles

All Health and Healthcare Articles

Cancer Genetics to Acquire Assets of Response Genetics

2 Analysts Continue to Like Shire-Baxalta Deal Pursuit

Massive Additional Gains in Aquinox Driven by Large Shareholder Stake

MannKind Cheered Despite Lower Afrezza Shipments

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

Janney Sees IBM and Merge Healthcare as Inconsequential

Key Analyst Sees Mylan as a Value Play

DepoMed Fires Back at Horizon Pharma

Can Aquinox Sustain Its Massive Rally?

5 Big FDA Decisions Expected in August

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

What to Expect From Allergan Earnings

Will Biogen Win From Novartis MS Drug Safety Label Change?

Starboard Value Sets Its Eyes on MedAssets

UBS Makes August Changes to Equity Focus List Portfolio

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

Why SpaceX Is About to Spend Billions on Something It Can’t Launch

Emerging Markets Are Embarrassing the S&P 500: EEM Up 28% YTD

Featured Reads

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

The 401(k) Bracket Smoothing Math: Why a 66 Year Old Couple With $1.5 Million Should Convert Exactly $90,000 a Year